Results 101 to 110 of about 118,146 (299)

A gateway to more productive research on e-cigarettes? Commentary on a comprehensive framework for evaluating public health impact [PDF]

open access: yes, 2017
Commentary to: A framework for evaluating the public health impact of e-cigarettes and other vaporized nicotine ...
Brown, J
core   +1 more source

Wireless blood pressure sensor implantation in sheep: A detailed technique

open access: yesAnimal Models and Experimental Medicine, EarlyView.
Twelve adult sheep underwent wireless blood pressure sensor implantation. The procedure lasted an average of 36 min, with mean systolic and diastolic blood pressures of 93 ± 6 and 65 ± 5 mmHg, respectively. This rapid, minimally invasive protocol is a powerful platform for cardiovascular device development.
David Santer   +10 more
wiley   +1 more source

Deregulate E-Cigarettes [PDF]

open access: yesThe American Journal of Medicine, 2021
openaire   +2 more sources

Characterizing Polytobacco Use Trajectories and Their Associations With Substance Use and Mental Health Across Mid-Adolescence. [PDF]

open access: yes, 2018
Background:Polytobacco product use is suspected to be common, dynamic across time, and increase risk for adverse behavioral outcomes. We statistically modeled characteristic types of polytobacco use trajectories during mid-adolescence and tested their ...
Barrington-Trimis, Jessica L   +8 more
core   +1 more source

Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou   +2 more
wiley   +1 more source

To 'Vape' or Smoke? A Discrete Choice Experiment among Adult Smokers

open access: yes, 2017
A growing share of the United States population uses e-cigarettes. In response, policymakers are considering regulating e-cigarettes, or have already done so, due to concerns regarding e-cigarettes' public health impact.
Buckell, John   +3 more
core  

Analysis of interstitial lung disease in pharmacovigilance databases: Coding challenges and interpretation biases—An update

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Clinically, interstitial lung disease (ILD) is a heterogeneous group of respiratory disorders. Due to their low incidence, pharmacovigilance database analysis is useful to detect them. Precise diagnosis is challenging as well as coding in these databases. Query criteria are among the key elements for a good signal detection.
Romane Freppel   +4 more
wiley   +1 more source

Gender differences in preferences, gateway effects, and potential motivations among e-cigarette users in China

open access: yesFrontiers in Public Health
ObjectiveA cross-sectional survey was conducted to investigate the differences in preferences, gateway effects, and potential motivations for e-cigarette use among different genders of e-cigarette users in China, thereby providing ideas for the ...
Wei Ji   +16 more
doaj   +1 more source

Personal Sentiment and Marketing of Electronic Cigarettes Among Twitter Users [PDF]

open access: yes, 2016
poster abstractThe use of electronic cigarettes (e-cigarettes) is growing in the United States and there is increasing controversial dialogue surrounding e-cigarettes on social media, including Twitter.
Lomax, Victoria   +2 more
core  

Early clinical pharmacology evaluation of the novel anti‐inflammatory macrolide, glasmacinal (EP395): tolerability, pharmacokinetics and drug interactions

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims This work assessed the pharmacokinetics (PK), safety and tolerability of glasmacinal (EP395, an oral anti‐inflammatory macrolide with negligible antimicrobial activity in development for COPD treatment) in two healthy participant trials: ‘first‐in‐human’ (FIH) and ‘drug–drug‐interaction’ (DDI).
Dave Singh   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy